Thioctic acid
Japan Standards for Cosmetics: Thioctic acid
The provisional English translation of the MHLW Standards for Cosmetics lists this ingredient with the stated limit or use matrix.
Décision réglementaire et conditions complètes
- Statut
- Restricted
- Rôle juridique
- Binding rule
- Résumé réglementaire
- The provisional English translation of the MHLW Standards for Cosmetics lists this ingredient with the stated limit or use matrix.
- Conditions et restrictions
Published three-column use matrix (rinse-off / leave-on / mucosal; blank means prohibited, ○ means no upper limit): 0.01 0.01
Identité de la substance
- Nom dans la source officielle
- Thioctic acid
- CAS
- 1077-28-7
- EC
- 214-071-2
- Correspondance d’identité
- exact INCI name
- Ingrédient associé
- THIOCTIC ACID
Données d’identité CosIng associées
Noms et alias
Description CosIng : 1,2-Dithiolane-3-pentanoic acid, (+/-)-
Fonction cosmétique enregistrée : ANTIOXIDANT
Pages de fonctions :ANTIOXIDANT
Voir le profil complet de l’ingrédientAperçu multi-marchés pour cette identité
Fiches exactes associées actuellement présentes sur ce site. L’absence d’un marché signifie qu’aucune correspondance exacte n’a été importée, et non une autorisation d’utiliser la substance.
Japan
Fiche actuelle1 fiche associée · 1 avec conditions spécifiques
Ouvrir la fiche justificative
Chimie vérifiée pour le CAS 1077-28-7
alpha Lipoic acid
Lipoic acid is a heterocyclic thia fatty acid comprising pentanoic acid with a 1,2-dithiolan-3-yl group at the 5-position. It has a role as a geroprotector and a fundamental metabolite. It is a member of dithiolanes, a heterocyclic fatty acid and a thia fatty acid. It is functionally related to an octanoic acid. It is a conjugate acid of a lipoate. — ChEBI
- Nom IUPAC
- 5-(dithiolan-3-yl)pentanoic acid
- Formule moléculaire
- C8H14O2S2
- Masse moléculaire
- 206.3 g/mol
- Masse exacte
- 206.04352203 Da
- Masse monoisotopique
- 206.04352203 Da
- XLogP3
- 1,7
- Surface polaire topologique
- 87,9 Ų
- Complexité moléculaire
- 150,0
- Charge formelle
- 0
- Donneurs de liaisons hydrogène
- 1
- Accepteurs de liaisons hydrogène
- 4
- Liaisons rotatives
- 5
- Atomes lourds
- 12
- Unités covalentes
- 1
Noms et synonymes signalés à PubChem
16 autres noms signalés
Identifiants de bases de données externes
- ChEBI:CHEBI:16494
- ChEMBL:CHEMBL33864
- EPA DTXSID:DTXSID7025508
- PubMed:22654724
- PubMed:22448096
- PubMed:22384101
- PubMed:22374556
- PubMed:22363901
- PubMed:22272085
- PubMed:22242957
- PubMed:22163871
- PubMed:22163517
- PubMed:22146387
- PubMed:22125679
- PubMed:22125537
Statistiques de structure avancées
- Stéréocentres atomiques définis
- 0
- Stéréocentres atomiques non définis
- 1
- Stéréocentres de liaison définis
- 0
- Stéréocentres de liaison non définis
- 0
- Caractéristiques pharmacophoriques 3D
- 5
- Cycles 3D
- 1
- Groupes hydrophobes 3D
- 1
- Caractéristiques d’accepteur 3D
- 2
- Caractéristiques de donneur 3D
- 0
- Centres anioniques 3D
- 1
- Centres cationiques 3D
- 0
- Conformères 3D
- 10
- Rotors 3D effectifs
- 6,0
Identifiants de structure lisibles par machine
- SMILES
C1CSSC1CCCCC(=O)O- InChI
InChI=1S/C8H14O2S2/c9-8(10)4-2-1-3-7-5-6-11-12-7/h7H,1-6H2,(H,9,10)- InChIKey
AGBQKNBQESQNJD-UHFFFAOYSA-N
Preuves issues de bases de données scientifiques complémentaires
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
- Color/Form: Forms yellowish flakes Source: Hazardous Substances Data Bank (HSDB)
- Dissociation Constants: pKa = 5.10 Source: Hazardous Substances Data Bank (HSDB)
- Melting Point: 47.5-48 °C Source: Hazardous Substances Data Bank (HSDB)
- Solubility: Yellow powder; solubility in ethanol: 50 mg/mL /Synthetic, oxidized form/ Source: Hazardous Substances Data Bank (HSDB)
- Solubility: Soluble in methanol, ethanol, diethyl ether and chloroform Source: Hazardous Substances Data Bank (HSDB)
- Carcinogen Classification: No indication of carcinogenicity to humans (not listed by IARC). Source: Toxin and Toxin Target Database (T3DB)
- Note: This chemical does not meet GHS hazard criteria for 6.5% (28 of 430) of reports. Source: European Chemicals Agency (ECHA)
- Signal: Warning Source: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H302 (93.5%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (48.6%): Causes skin irritation [Warning Skin corrosion/irritation]; H317 (46.5%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H319 (47%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H411 (46.5%): Toxic to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard] Source: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P261, P264, P264+P265, P270, P272, P273, P280, P301+P317, P302+P352, P305+P351+P338, P321, P330, P332+P317, P333+P317, P337+P317, P362+P364, P391, and P501 (click each P-code to see the statement) Source: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 430 reports by companies from 16 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 28 of 430 reports by companies.; There are 14 notifications provided by 402 of 430 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
- Note: This chemical does not meet GHS hazard criteria for 42.3% (52 of 123) of reports. Source: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H302 (57.7%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (31.7%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (31.7%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335 (31.7%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]; H412 (19.5%): Harmful to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard] Source: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P261, P264, P264+P265, P270, P271, P273, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement) Source: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 123 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 52 of 123 reports by companies.; There are 7 notifications provided by 71 of 123 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
- Health Effects: Acute exposure to cholinesterase inhibitors can cause a cholinergic crisis characterized by severe nausea/vomiting, salivation, sweating, bradycardia, hypotension, collapse, and convulsions. Increasing muscle weakness is a possibility and may result in death if respiratory muscles are involved. Accumulation of ACh at motor nerves causes overstimulation of nicotinic expression at the neuromuscular junction. When this occurs symptoms such as muscle weakness, fatigue, muscle cramps, fasciculation, and paralysis can be seen. When there is an accumulation of ACh at autonomic ganglia this causes overstimulation of nicotinic expression in the sympathetic system. Symptoms associated with this are hypertension, and hypoglycemia. Overstimulation of nicotinic acetylcholine receptors in the central nervous system, due to accumulation of ACh, results in anxiety, headache, convulsions, ataxia, depression of respiration and circulation, tremor, general weakness, and potentially coma. When there is expression of muscarinic overstimulation due to excess acetylcholine at muscarinic acetylcholine receptors symptoms of visual disturbances, tightness in chest, wheezing due to bronchoconstriction, incre Source: Toxin and Toxin Target Database (T3DB)
- Toxicity Summary: ALA is generally considered a safe drug. A daily dose of 200 mg/day to 2400 mg/day of ALA is deemed safe without significant adverse effects. However, there is no reported safe dose in children.; A notable case in literature demonstrated status epilepticus (SE) that subsided within a few days. The seizures were treated per normal standards for SE.; In the last 2 decades, there have been few reported cases of ALA toxicity in humans. Most of these cases occur in children and are treatable. Though there is no established lethal dosage of ALA for humans, studies have shown that a high dose of 121 mg/kg body weight/day was associated with alterations in liver enzymes and liver function. Therefore, there are potentially harmful adverse effects from overdosing on ALA, and more studies are necessary to determine the toxicity. Source: StatPearls
- Toxicity Summary: (R)-lipoic acid is a cholinesterase or acetylcholinesterase (AChE) inhibitor. A cholinesterase inhibitor (or 'anticholinesterase') suppresses the action of acetylcholinesterase. Because of its essential function, chemicals that interfere with the action of acetylcholinesterase are potent neurotoxins, causing excessive salivation and eye-watering in low doses, followed by muscle spasms and ultimately death. Nerve gases and many substances used in insecticides have been shown to act by binding a serine in the active site of acetylcholine esterase, inhibiting the enzyme completely. Acetylcholine esterase breaks down the neurotransmitter acetylcholine, which is released at nerve and muscle junctions, in order to allow the muscle or organ to relax. The result of acetylcholine esterase inhibition is that acetylcholine builds up and continues to act so that any nerve impulses are continually transmitted and muscle contractions do not stop. Among the most common acetylcholinesterase inhibitors are phosphorus-based compounds, which are designed to bind to the active site of the enzyme. The structural requirements are a phosphorus atom bearing two lipophilic groups, a leaving group (such as Source: Toxin and Toxin Target Database (T3DB)
- Uses: Nutrition, biochemical research /Thioctic acid, dl-form/ Source: Hazardous Substances Data Bank (HSDB)
- Uses: THERAPEUTIC CATEGORY: Treatment of liver disease; antidote to poisonous mushrooms (Amanita species). Source: Hazardous Substances Data Bank (HSDB)
- Uses: Use (kg; approx.) in Germany (2009): >7500; Consumption (g per capita; approx.) in Germany (2009): 0.0916; Calculated removal (%): 96.4 Source: NORMAN Suspect List Exchange
- Uses: For nutritional supplementation, also for treating dietary shortage or imbalance. Source: Toxin and Toxin Target Database (T3DB)
Mis en correspondance par: Existing checksum-valid CAS to unique PubChem CID match. Récupéré le: 2026-08-31. Ouvrir la fiche source
Les classifications scientifiques et les annotations de danger apportent du contexte et ne remplacent pas la décision réglementaire propre au marché indiquée ci-dessus.
Couverture des sources complémentaires et état des correspondances
| Source | Résultat | Vérifié |
|---|---|---|
| NIH PubChem PUG-View | Correspondance exacte | 2026-08-31 |
Une absence de correspondance enregistrée est une preuve utile que la source a été vérifiée ; ce n’est pas l’affirmation que la substance n’existe pas ailleurs.
Récupéré depuis NIH PubChem le 2026-09-02 par correspondance CAS à somme de contrôle valide. Les propriétés chimiques ne remplacent pas la décision réglementaire de cette page.
Source officielle et provenance
- Source enregistrée
- Japan MHLW Standards for Cosmetics
- Référence de la source
- Appendix 2 section 3, entry 2
- Identifiant de la fiche source
appendix-2-3:2- Version de la source
- MHLW Notification No. 331 provisional translation, retrieved 2026-08-30
- Langue de la source
- English provisional translation; Japanese text is canonical
- État de la traduction
- Regulator-hosted provisional English translation · Traduction anglaise
- Instantané vérifié le
- 2026-08-30 04:11 UTC
- Méthode de validation
- pdftotext -layout plus strict per-table row counts
- SHA-256
117fc949a82789ca66017163f19041cf2fcf6b5902708077c8e4f56c482dc8e2
Notes du jeu de données enregistré
- Couverture du jeu de données
- Prohibited and restricted ingredient appendices with concentration and use conditions
- Note sur l’autorité
- Official MHLW standard; validate later Japanese updates before presenting current status
Place de cette fiche dans le jeu de données du marché
Répartition des statuts
Un texte de conditions est présent pour 117 des 117 fiches actuelles. Un champ de conditions vide est interprété selon le type de fiche ci-dessus ; il n’est jamais converti en une affirmation d’utilisation sans restriction.
Japan contexte du marché
Complete Standards appendices dataset
Version de la couverture : MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot
Prohibited ingredients, restricted ingredients and permitted preservative/UV/colourant appendices present in the official standard source.
Liste de contrôle de vérification
- Search Japanese/English identity and CAS where present.
- Apply category and maximum-amount conditions.
- Check later MHLW notices against the Japanese source.
- Verify marketing licence, notification, labelling and quasi-drug classification.
Sources officielles du marché
- Japan MHLW Standards for CosmeticsOfficial MHLW standard; validate later Japanese updates before presenting current status
Procédure de vérification et exhaustivité de la fiche
Avant d’utiliser ce résultat dans une décision de conformité
- Confirmez que « Thioctic acid » et chaque identifiant CAS/CE correspondent à la matière de votre spécification fournisseur.
- Search Japanese/English identity and CAS where present.
- Apply category and maximum-amount conditions.
- Check later MHLW notices against the Japanese source.
- Verify marketing licence, notification, labelling and quasi-drug classification.
- Consignez la version de la source et revérifiez auprès de l’autorité de réglementation avant la fabrication, la notification ou la mise sur le marché.
Champs disponibles dans cette fiche
- Nom officiel de la substanceDisponible
- CASDisponible
- ECDisponible
- Texte de condition distinctDisponible
- Date d’effetNon fourni
- Empreinte de l’instantané et méthodeDisponible
Questions auxquelles cette page répond
Citation stable
Thioctic acid. Appendix 2 section 3, entry 2. Japan. Source version MHLW Notification No. 331 provisional translation, retrieved 2026-08-30. CosIng Checker regulatory record: https://cosingchecker.com/fr/regulations/jp/records/633/
Citez l’autorité de réglementation comme autorité juridique. Cette page est un index structuré de preuves et une aide à la vérification, et non un substitut au texte officiel ni à une évaluation juridique professionnelle.
Interprétation et limites pour Japan
This substance is not unrestricted: cosmetic use is subject to the conditions in the cited official record.
Check product type, body area, concentration, purity and warning requirements before deciding whether a formulation is compliant.
Comment interpréter le rôle juridique
The cited row forms part of a binding rule or legally incorporated list for this market.
Preuves sur cette page
- Résultat enregistré : Restricted
- Rôle juridique : Binding rule
- Version de la source : MHLW Notification No. 331 provisional translation, retrieved 2026-08-30
Ce que cela ne prouve pas
The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion.
Recherche complémentaire sur la substance auprès de sources faisant autorité
Aucune de ces sources ne prévaut sur la décision de marché ci-dessus.
Cosmetic Ingredient Review safety assessments
Expert Panel conclusions, assessed ingredient groups, use conditions, dates and report documents
Independent expert review considered by FDA; not a government approval or binding market rule
Rechercher cette identité à la sourceFDA Global Substance Registration System
UNII identifiers, preferred names, substance types, codes and public substance relationships
Identity registry only; UNII availability does not imply FDA review or approval
Rechercher cette identité à la sourceILO/WHO International Chemical Safety Cards
Hazards, symptoms, first aid, storage, incompatibilities and physical properties for covered chemicals
International occupational chemical-safety reference; not cosmetic-use approval
Rechercher cette identité à la sourceJapan NITE-CHRIP
Chemical identity, Japanese and foreign legal lists, GHS hazards and exposure-related information
Chemical-management evidence; cosmetic status remains governed by the applicable MHLW standard and market rules
Rechercher cette identité à la sourceNIOSH Pocket Guide to Chemical Hazards
REL, PEL, IDLH, properties, exposure routes, symptoms, target organs, first aid and measurement methods for covered workplace chemicals
US occupational-health guidance and limits; not a cosmetic ingredient decision
Rechercher cette identité à la sourceOECD eChemPortal
Gateway to authority-owned physical-property, fate, ecotoxicity, toxicity, exposure and GHS records
Discovery gateway; each linked authority remains responsible for its data
Rechercher cette identité à la sourceUS EPA CompTox CTX APIs
Clé d’API requise pour l’importDTXSID identity, experimental and predicted properties, toxicity, bioactivity, exposure and environmental data
Scientific and computational evidence; predictions must remain labelled and do not determine cosmetic legality
Rechercher cette identité à la source